About us
The team
Servatrix Biomed S.L. is a spin-off of Autonomous University of Marid (UAM), that has been created to develop a patent protected pipeline of NRF2 activators for the use in chronic diseases such as NASH. This pharmacological pipeline is the result of over 15 years of research on this target by the scientific team established at the UAM, and brings an innovative approach to NASH, based on the mild but chronic activation of NRF2 at close to physiological levels.
Servatrix current structure is highly connected with the UAM through a collaborative program. The current structure of the company supports the non-clinical strategy and will be modified towards the advancement to clinical trials…
Servatrix Biomed
SIAB | Scientific & Industry Advisory Board
Other investors and advisors
Meet the team
Contact us by email to get:
- More info about Servatrix Projects.
- A confidential sample of Servatrix Investment Deck.
- Meeting with our technical team and founders.
